Resumes
Resumes
Rama Karri
View pageLocation:
United States
Rama Karri Phones & Addresses
-
Franklin Park, NJ
-
2222 Quail Ridge Dr, Plainsboro, NJ 08536 (609) 750-0824
-
Bracey, VA
-
816 Regency Dr, Franklin Park, NJ 08823
Work
Position:
Clerical/White Collar
Education
Degree:
Associate degree or higher
Publications
Us Patents
Stable Tablet Dosage Forms Of Proton Pump Inhibitors
View pageUS Patent:
20060210637, Sep 21, 2006
Filed:
Mar 17, 2005
Appl. No.:
11/082610
Inventors:
Ranga Namburi - Plainsboro NJ, US
Rama Karri - Plainsboro NJ, US
Ravi Tallapragada - Plainsboro NJ, US
Burgise Palkhiwala - East Windsor NJ, US
Rama Karri - Plainsboro NJ, US
Ravi Tallapragada - Plainsboro NJ, US
Burgise Palkhiwala - East Windsor NJ, US
International Classification:
A61K 31/4439
A61K 9/14
A61K 9/26
A61K 9/14
A61K 9/26
US Classification:
424489000, 514338000, 424469000
Abstract:
This invention relates to a method of making oral formulations of practically water insoluble, or very slightly water soluble proton pump inhibitors, the oral dosage forms so made, and methods of use thereof. The oral dosage form has a core tablet of compressed particles composed of powder particles of a pharmaceutically acceptable material, having coated thereon admixture of an amorphous, salt form of a benzimidazole proton pump inhibitor produced in-situ; and a pharmaceutically acceptable, water-soluble, hydrophilic polymer having a surfactant functionality. The coated core tablet has a pharmaceutically acceptable sub-coating on the core tablet; and a pharmaceutically acceptable enteric coating on the sub-coating. The coated tablet may provide enhanced absorption when administered orally.
Stable Tablet Dosage Forms Of Proton Pump Inhibitors
View pageUS Patent:
20080057125, Mar 6, 2008
Filed:
Sep 4, 2007
Appl. No.:
11/849505
Inventors:
Ranga Namburi - Plainsboro NJ, US
Rama Karri - Plainsboro NJ, US
Ravi Tallapragada - Plainsboro NJ, US
Rama Karri - Plainsboro NJ, US
Ravi Tallapragada - Plainsboro NJ, US
International Classification:
A61K 9/30
A61K 31/4439
A61K 9/36
A61K 31/4439
A61K 9/36
US Classification:
424475000, 424465000, 424480000, 514338000
Abstract:
This invention relates to a method of making oral formulations of practically water insoluble, or very slightly water soluble proton pump inhibitors, the oral dosage forms so made, and methods of use thereof. The oral dosage form has a core tablet of compressed particles composed of powder particles of a pharmaceutically acceptable material, having coated thereon admixture of an amorphous, salt form of a benzimidazole proton pump inhibitor produced in-situ; and a pharmaceutically acceptable, water-soluble, hydrophilic polymer having a surfactant functionality. The coated core tablet has a pharmaceutically acceptable sub-coating on the core tablet; and a pharmaceutically acceptable enteric coating on the sub-coating. The coated tablet may provide enhanced absorption when administered orally.
Solution Forms Of Cyclodextrins For Nasal Or Throat Delivery Of Essential Oils
View pageUS Patent:
20060120967, Jun 8, 2006
Filed:
Dec 7, 2004
Appl. No.:
11/005958
Inventors:
Ranga Namburi - Plainsboro NJ, US
Sucharitha Jagini - Edison NJ, US
Rama Karri - Plainsboro NJ, US
Burgise Palkhiwala - East Windson NJ, US
Sucharitha Jagini - Edison NJ, US
Rama Karri - Plainsboro NJ, US
Burgise Palkhiwala - East Windson NJ, US
International Classification:
A61L 9/04
A61K 36/328
A61K 36/48
A61K 36/28
A61K 31/724
A61K 36/328
A61K 36/48
A61K 36/28
A61K 31/724
US Classification:
424045000, 514058000, 424748000, 424757000, 424764000, 424641000
Abstract:
This invention further relates to a method for preventing or treating diseases or conditions of the oral cavity, throat or nose of warm-blooded animals including humans. More particularly, the invention pertains to a composition and method for spraying essential oils to the oral cavity, throat or nasal mucosa as cyclodextrin inclusion complexes. The spray composition includes a cyclodextrin in an amount of from about 0.1% w/v to about 20% w/v; at least one essential oil in an amount of from about 0.001% w/v to about 5.0% w/v; an effective amount of an antimicrobial preservative composition; and water. The composition may further comprise an alcohol co-solvent, a thickening agent, a sweetener, an antitussive, an anticholinergic, a decongestant, an antihistamine, an astringent, an anti-inflammatory steroid composition, a vitamin, a respiratory stimulant, a mucolytic agent, a bronchodilator, a beta-antagonist, an antidiarrheal agent, or combinations thereof.